Blue-chip companies rightfully make up the bulk of most people’s investment portfolios. These large-cap firms possess considerable industry leverage, as well as a vast sum of financial resources. Their status and importance to the underlying economy means that they are the least likely to crumble, regardless of external pressures. Ultimately, blue chips provide the confidence and stability to which you can pin your long-term hopes.
Source: slgckgc via Flickr (Modified)But there’s a reason most financial advisers say to have at least a small allocation to speculative investments. Those large caps can offer somewhat modest returns. Single-digit annual gains and a 2% dividend yield? No … here and there, investors should try to generate bigger returns from more explosive small- and even micro-cap stocks.
Top 10 Blue Chip Stocks To Invest In 2019: Ambarella, Inc.(AMBA)
Advisors' Opinion:- [By Stephan Byrd]
Ambarella Inc (NASDAQ:AMBA) insider Leslie Kohn sold 6,799 shares of the business’s stock in a transaction that occurred on Wednesday, September 19th. The shares were sold at an average price of $35.46, for a total value of $241,092.54. Following the completion of the sale, the insider now owns 916,795 shares of the company’s stock, valued at $32,509,550.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
- [By Nicholas Rossolillo]
Video chip maker Ambarella's (NASDAQ:AMBA) claim to fame was making crucial hardware for action camera company GoPro. That main business has been in decline, though, leaving Ambarella shareholders with a stock that has been stuck in a rut the last few years. However, a new technology -- computer vision -- has management optimistic that a new revenue source is in the works.
- [By Chris Hill]
On the other side of the overreaction coin, video-processing chipmaker Ambarella (NASDAQ:AMBA) dropped a whopping 13% on its quarterly report, but the company's long-term outlook is a bit less rosy. The mysterious JPHathAzon healthcare company has reportedly decided on a CEO, but further details haven't yet been released. And Warren Buffett and Jamie Dimon are weighing in on quarterly expectations culture. Click play and find out more.
Top 10 Blue Chip Stocks To Invest In 2019: Infinity Pharmaceuticals, Inc.(INFI)
Advisors' Opinion:- [By Logan Wallace]
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) CEO Adelene Q. Perkins sold 5,000 shares of Infinity Pharmaceuticals stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $2.82, for a total transaction of $14,100.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Infinity Pharmaceuticals (INFI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Chris Lange]
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares made a healthy gain early on Tuesday after the firm announced a collaboration with Arcus Biosciences Inc. (NYSE: RCUS). These two companies have entered into a clinical collaboration to evaluate two triple combination therapies in selected tumor types that typically show minimal response to checkpoint inhibition monotherapy.
- [By Logan Wallace]
ValuEngine upgraded shares of Infinity Pharmaceuticals (NASDAQ:INFI) from a sell rating to a hold rating in a report published on Saturday morning.
Top 10 Blue Chip Stocks To Invest In 2019: DHI Group, Inc.(DHX)
Advisors' Opinion:- [By Lisa Levin]
Friday afternoon, the information technology shares surged 1.83 percent. Meanwhile, top gainers in the sector included Zuora, Inc. (NYSE: ZUO), up 22 percent, and DHI Group, Inc. (NYSE: DHX) up 30 percent.
- [By Joseph Griffin]
DHX Media (TSE:DHX) had its target price decreased by research analysts at CIBC from C$3.00 to C$2.00 in a research report issued on Wednesday. CIBC’s price objective points to a potential downside of 0.50% from the stock’s current price.
- [By Shane Hupp]
DHX Media Ltd. (TSE:DHX) – National Bank Financial issued their FY2020 earnings per share estimates for DHX Media in a research report issued to clients and investors on Wednesday, September 26th. National Bank Financial analyst A. Shine anticipates that the company will post earnings of ($0.01) per share for the year. National Bank Financial has a “Sector Perform” rating and a $1.50 price objective on the stock.
Top 10 Blue Chip Stocks To Invest In 2019: Sinovac Biotech Ltd.(SVA)
Advisors' Opinion:- [By Joseph Griffin]
News articles about Sinovac Biotech (NASDAQ:SVA) have been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sinovac Biotech earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned media stories about the biopharmaceutical company an impact score of 45.8977999719642 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Top 10 Blue Chip Stocks To Invest In 2019: Pagegroup PLC (PAGE)
Advisors' Opinion:- [By Max Byerly]
Pagegroup (LON:PAGE) had its target price raised by UBS Group from GBX 550 ($7.09) to GBX 600 ($7.74) in a report released on Monday, investing.thisismoney.co.uk reports. They currently have a neutral rating on the stock.
- [By Ethan Ryder]
Pagegroup PLC (LON:PAGE) declared a dividend on Wednesday, August 8th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, September 6th will be paid a dividend of GBX 16.83 ($0.22) per share on Wednesday, October 10th. This represents a dividend yield of 2.81%. The ex-dividend date is Thursday, September 6th. This is a positive change from Pagegroup’s previous dividend of $8.60. The official announcement can be accessed at this link.
Top 10 Blue Chip Stocks To Invest In 2019: John B. Sanfilippo & Son, Inc.(JBSS)
Advisors' Opinion:- [By Stephan Byrd]
WINTON GROUP Ltd acquired a new position in shares of John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 21,466 shares of the company’s stock, valued at approximately $1,242,000. WINTON GROUP Ltd owned about 0.19% of John B. Sanfilippo & Son at the end of the most recent quarter.
- [By Max Byerly]
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) shares reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $71.43 and last traded at $70.96, with a volume of 1305 shares trading hands. The stock had previously closed at $69.72.
- [By Joseph Griffin]
BidaskClub upgraded shares of John B. Sanfilippo & Son (NASDAQ:JBSS) from a hold rating to a buy rating in a research note released on Wednesday.
- [By Logan Wallace]
Legal & General Group Plc increased its position in shares of John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) by 6.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,366 shares of the company’s stock after acquiring an additional 1,126 shares during the quarter. Legal & General Group Plc owned about 0.15% of John B. Sanfilippo & Son worth $1,300,000 as of its most recent SEC filing.
- [By Max Byerly]
The Hershey (NYSE: HSY) and John B. Sanfilippo & Son (NASDAQ:JBSS) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.
- [By Ethan Ryder]
John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) CEO Jeffrey T. Sanfilippo sold 8,108 shares of the firm’s stock in a transaction that occurred on Thursday, August 30th. The shares were sold at an average price of $71.00, for a total transaction of $575,668.00. Following the completion of the sale, the chief executive officer now directly owns 14,840 shares in the company, valued at approximately $1,053,640. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Top 10 Blue Chip Stocks To Invest In 2019: Murphy Oil Corporation(MUR)
Advisors' Opinion:- [By Logan Wallace]
Texas Permanent School Fund cut its holdings in Murphy Oil Co. (NYSE:MUR) by 2.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 104,981 shares of the oil and gas producer’s stock after selling 2,410 shares during the period. Texas Permanent School Fund owned approximately 0.06% of Murphy Oil worth $3,545,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Shane Hupp]
Get a free copy of the Zacks research report on Murphy Oil (MUR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Shares of Murphy Oil Co. (NYSE:MUR) have earned an average recommendation of “Hold” from the thirteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $33.11.
- [By Matthew DiLallo]
Shares of Murphy Oil Corporation (NYSE:MUR) took off on Thursday, rising more than 12% by 10:30 a.m. EDT after the company agreed to form a strategic joint venture (JV) with Petrobras (NYSE:PBR) in the Gulf of Mexico.
- [By Stephan Byrd]
Murphy Oil Co. (NYSE:MUR) has earned an average rating of “Hold” from the twelve analysts that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $31.56.
Top 10 Blue Chip Stocks To Invest In 2019: Merrimack Pharmaceuticals, Inc.(MACK)
Advisors' Opinion:- [By Shane Hupp]
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares reached a new 52-week low on Thursday . The stock traded as low as $4.56 and last traded at $4.71, with a volume of 33598 shares. The stock had previously closed at $4.74.
- [By Max Byerly]
Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK) by 22.0% in the second quarter, HoldingsChannel.com reports. The fund owned 174,774 shares of the biopharmaceutical company’s stock after acquiring an additional 31,509 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Merrimack Pharmaceuticals were worth $858,000 as of its most recent filing with the SEC.
- [By Max Byerly]
Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:
Get Merrimack Pharmaceuticals alerts: Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod (finance.yahoo.com) Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains (seekingalpha.com) Merrimack Pharmaceuticals’ (MACK) “Hold” Rating Reaffirmed at Robert W. Baird (americanbankingnews.com) Merrimack Crashes as Phase II Pancreatic Cancer Study Fails (zacks.com) MM-141 (benzinga.com)Several equities analysts have commented on MACK shares. Zacks Investment Research raised Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Wednesday, April 25th. JPMorgan Chase & Co. downgraded Merrimack Pharmaceuticals from a “neutral” rating to an “underweight” rating in a research report on Monday. Robert W. Baird cut their price objective on Merrimack Pharmaceuticals from $12.00 to $7.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, ValuEngine raised Merrimack Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Tuesday.
Top 10 Blue Chip Stocks To Invest In 2019: Galaxy Resources Limited (GALXF)
Advisors' Opinion:- [By ]
Galaxy Resources [ASX:GXY] (OTCPK:GALXF) - Price = AUD 3.42
Galaxy Resources is an Australian pure play lithium miner with 3 lithium projects globally.
Top 10 Blue Chip Stocks To Invest In 2019: NCI Building Systems, Inc.(NCS)
Advisors' Opinion:- [By Max Byerly]
NCI Building Systems Inc (NYSE:NCS) – Analysts at Seaport Global Securities upped their Q3 2018 earnings estimates for NCI Building Systems in a report issued on Wednesday, June 6th. Seaport Global Securities analyst M. Mccall now forecasts that the construction company will post earnings per share of $0.50 for the quarter, up from their prior estimate of $0.44. Seaport Global Securities also issued estimates for NCI Building Systems’ FY2018 earnings at $1.45 EPS.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on NCI Building Systems (NCS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
NCI Building Systems (NYSE:NCS) issued its earnings results on Tuesday. The construction company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.03, RTT News reports. The firm had revenue of $548.50 million for the quarter, compared to the consensus estimate of $534.27 million. NCI Building Systems had a net margin of 1.92% and a return on equity of 23.45%. The business’s revenue was up 16.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.27 earnings per share.
- [By Logan Wallace]
NCI Building Systems Inc (NYSE:NCS) was the target of unusually large options trading on Tuesday. Stock traders bought 1,048 put options on the company. This represents an increase of 1,356% compared to the typical daily volume of 72 put options.
No comments:
Post a Comment